Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) uses a radioactive tracer, that binds to PSMA protein, which has better diagnostic accuracy than CT and bone scan for prostate cancer due to PSMA protein over-expression [8]. This evidence concerns the gene FOLH1 and prostate carcinoma.